46
NPS Score
VS
Incyte
- EMPLOYEE
PARTICIPANTS - 23
- TOTAL
RATINGS
Karyopharm Therapeutics Claimed Company
- This companyis accepting feedback from verified employeesEMPLOYEE
PARTICIPANTS - 90
- TOTAL
RATINGS
Incyte vs Karyopharm Therapeutics
Compare Incyte versus Karyopharm Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 23 employees and customers of Incyte and 90 employees and customers of Karyopharm Therapeutics.
Incyte
Incyte's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Incyte.
Karyopharm Therapeutics
Karyopharm Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Karyopharm Therapeutics. Their current market cap is $753.30M.
3.9/5
Product Quality
5/5
3.9/5
Pricing
5/5
3.8/5
Customer Service
5/5
| 69% | Promoters |
|---|---|
| 8% | Passive |
| 23% | Detractors |
100
NPS Score
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
Net Promoter Score
Winner by 54
See how Incyte compares to its competitors
See how Karyopharm Therapeutics compares to its competitors
Working at Incyte vs Working at Karyopharm Therapeutics
83 / 100
CEO Rating
Winner by 1%
82 / 100
CEO Rating
Incyte
Incyte doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Karyopharm Therapeutics
Employees at Karyopharm Therapeutics rate their CEO, Richard Paulson, 82/100. This score is 1% lower than the scores of Incyte's CEO, Hervé Hoppenot. Employees in the IT and Sales departments rate Richard Paulson the highest.